Hui‐Ling Yeoh

577 total citations
17 papers, 323 citations indexed

About

Hui‐Ling Yeoh is a scholar working on Oncology, Epidemiology and Surgery. According to data from OpenAlex, Hui‐Ling Yeoh has authored 17 papers receiving a total of 323 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 4 papers in Epidemiology and 3 papers in Surgery. Recurrent topics in Hui‐Ling Yeoh's work include Cancer Immunotherapy and Biomarkers (7 papers), Cutaneous Melanoma Detection and Management (5 papers) and CAR-T cell therapy research (4 papers). Hui‐Ling Yeoh is often cited by papers focused on Cancer Immunotherapy and Biomarkers (7 papers), Cutaneous Melanoma Detection and Management (5 papers) and CAR-T cell therapy research (4 papers). Hui‐Ling Yeoh collaborates with scholars based in Australia, United States and Switzerland. Hui‐Ling Yeoh's co-authors include Matteo S. Carlino, Alexander M. Menzies, Douglas B. Johnson, Georgina V. Long, Andrew Haydon, Aleigha Lawless, Suthee Rapisuwon, James R. Patrinely, Ryan J. Sullivan and Iman Osman and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Cochrane Database of Systematic Reviews.

In The Last Decade

Hui‐Ling Yeoh

16 papers receiving 320 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Hui‐Ling Yeoh Australia 7 182 98 52 49 38 17 323
Ajay Gupta India 9 127 0.7× 46 0.5× 50 1.0× 19 0.4× 30 0.8× 24 306
Cameron Schlegel United States 9 52 0.3× 55 0.6× 69 1.3× 56 1.1× 19 0.5× 21 302
Nara Lee South Korea 12 113 0.6× 77 0.8× 154 3.0× 52 1.1× 10 0.3× 51 494
Chia‐Lin Chou Taiwan 11 117 0.6× 65 0.7× 104 2.0× 17 0.3× 7 0.2× 39 311
Yuko Uehara Japan 9 59 0.3× 56 0.6× 25 0.5× 48 1.0× 7 0.2× 25 229
A.L. Frauchiger Switzerland 9 157 0.9× 37 0.4× 151 2.9× 25 0.5× 116 3.1× 13 388
Laura Winter United States 10 171 0.9× 24 0.2× 127 2.4× 35 0.7× 20 0.5× 20 538
Sang-Min Kim South Korea 7 90 0.5× 82 0.8× 61 1.2× 21 0.4× 14 0.4× 31 315
Anna Chichura United States 10 137 0.8× 17 0.2× 84 1.6× 93 1.9× 29 0.8× 27 356

Countries citing papers authored by Hui‐Ling Yeoh

Since Specialization
Citations

This map shows the geographic impact of Hui‐Ling Yeoh's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hui‐Ling Yeoh with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hui‐Ling Yeoh more than expected).

Fields of papers citing papers by Hui‐Ling Yeoh

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hui‐Ling Yeoh. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hui‐Ling Yeoh. The network helps show where Hui‐Ling Yeoh may publish in the future.

Co-authorship network of co-authors of Hui‐Ling Yeoh

This figure shows the co-authorship network connecting the top 25 collaborators of Hui‐Ling Yeoh. A scholar is included among the top collaborators of Hui‐Ling Yeoh based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hui‐Ling Yeoh. Hui‐Ling Yeoh is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

17 of 17 papers shown
1.
DiSipio, Tracey, Hui‐Ling Yeoh, Kathryn Alsop, et al.. (2025). Understanding Contemporary Endometrial Cancer Survivorship Issues: Umbrella Review and Healthcare Professional Survey. Cancers. 17(16). 2696–2696.
2.
Goodman, Rachel, Aleigha Lawless, Rachel Woodford, et al.. (2025). Characterizing Chronic Cutaneous Immune-Related Adverse Events Following Immune Checkpoint Inhibitors. JAMA Dermatology. 161(5). 555–555. 1 indexed citations
3.
Yeoh, Hui‐Ling, Eldho Paul, Bronwyn Levvey, et al.. (2024). Malignancy risk and mortality after lung transplantation: A single-institution experience over 31 years. SHILAP Revista de lepidopterología. 4. 100094–100094. 2 indexed citations
4.
Goodman, Rachel, Aleigha Lawless, Rachel Woodford, et al.. (2023). Extended Follow-Up of Chronic Immune-Related Adverse Events Following Adjuvant Anti–PD-1 Therapy for High-Risk Resected Melanoma. JAMA Network Open. 6(8). e2327145–e2327145. 30 indexed citations
5.
Bhave, Prachi, Angela Hong, Serigne Lo, et al.. (2023). Efficacy and toxicity of adjuvant radiotherapy in recurrent melanoma after adjuvant immunotherapy. Journal for ImmunoTherapy of Cancer. 11(3). e006629–e006629. 14 indexed citations
6.
Yeoh, Hui‐Ling, et al.. (2023). Immune-related adverse events secondary to immunotherapy in oncology: A guide for general practice. Australian Journal of General Practice. 52(6). 378–385. 1 indexed citations
7.
Goodman, Rachel, Aleigha Lawless, Rachel Woodford, et al.. (2023). Long-term outcomes of chronic immune-related adverse events from adjuvant anti-PD-1 therapy for high-risk resected melanoma.. Journal of Clinical Oncology. 41(16_suppl). 9591–9591. 3 indexed citations
8.
Yeoh, Hui‐Ling, et al.. (2022). Vitamin E in Cancer Treatment: A Review of Clinical Applications in Randomized Control Trials. Nutrients. 14(20). 4329–4329. 15 indexed citations
9.
Galea, Claire, Serigne Lo, Florentia Dimitriou, et al.. (2022). Efficacy and safety of "second adjuvant" therapy with BRAF/MEK inhibitors after resection of recurrent melanoma following adjuvant PD-1–based immunotherapy.. Journal of Clinical Oncology. 40(16_suppl). 9575–9575. 6 indexed citations
10.
Patrinely, James R., Aleigha Lawless, Prachi Bhave, et al.. (2021). Chronic Immune-Related Adverse Events Following Adjuvant Anti–PD-1 Therapy for High-risk Resected Melanoma. JAMA Oncology. 7(5). 744–744. 152 indexed citations
11.
Silva, Inês Pires da, Judith M. Versluis, Tasnia Ahmed, et al.. (2021). Patterns and management of progression on first-line ipilimumab combined with anti-PD-1 (IPI+PD1) in metastatic melanoma (MM) patients.. Journal of Clinical Oncology. 39(15_suppl). 9533–9533. 1 indexed citations
12.
Bhave, Prachi, Angela Hong, Alexander M. Menzies, et al.. (2021). Efficacy of adjuvant radiotherapy in recurrent melanoma after adjuvant immunotherapy.. Journal of Clinical Oncology. 39(15_suppl). 9578–9578. 1 indexed citations
13.
Barnes, Hayley, et al.. (2019). Prostacyclin for pulmonary arterial hypertension. Cochrane Database of Systematic Reviews. 2019(5). CD012785–CD012785. 46 indexed citations
14.
Yeoh, Hui‐Ling, Victoria Hall, Deborah A. Williamson, & Bradley J. Gardiner. (2019). Locally acquired extended‐spectrum β‐lactamase Shigella infection. The Medical Journal of Australia. 211(4). 163–163. 1 indexed citations
15.
Yeoh, Hui‐Ling, Allen Cheng, Catherine L. Cherry, et al.. (2017). Immunometabolic and Lipidomic Markers Associated With the Frailty Index and Quality of Life in Aging HIV+ Men on Antiretroviral Therapy. EBioMedicine. 22. 112–121. 30 indexed citations
16.
Yeoh, Hui‐Ling, Allen Cheng, Clovis S. Palmer, Suzanne M. Crowe, & Jennifer Hoy. (2017). Frailty in Men Living with HIV: A Cross-Sectional Comparison of Three Frailty Instruments. Antiviral Therapy. 23(2). 117–127. 17 indexed citations
17.
Cruz, Robyn Flaum, et al.. (2006). A Pilot Project on a Specialist Memory Clinic for People with Learning Disabilities. The British Journal of Development Disabilities. 52(102). 37–46. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ajay Gupta Breakdown of academic impact, for papers by Cameron Schlegel Breakdown of academic impact, for papers by Nara Lee Breakdown of academic impact, for papers by Chia‐Lin Chou Breakdown of academic impact, for papers by Yuko Uehara Breakdown of academic impact, for papers by A.L. Frauchiger Breakdown of academic impact, for papers by Laura Winter Breakdown of academic impact, for papers by Sang-Min Kim Breakdown of academic impact, for papers by Anna Chichura
Rankless by CCL
2026